Glossary entry (derived from question below)
English term or phrase:
Select Early vs Select Compare
French translation:
Select Early vs Select Compare
Added to glossary by
Bertrand Leduc
Nov 7, 2018 16:15
5 yrs ago
1 viewer *
English term
Canada
The passion of words, still and ever
Native in: French (Variant: Canadian) 
Works in: English to French
Select Early vs Select Compare
English to French
Medical
Medical: Pharmaceuticals
Études cliniques
Superior joint protection versus comparator (vs methotrexate in Select Early, vs placebo in Select Compare)
Dans la monographie d'un médicament
Dans la monographie d'un médicament
Proposed translations
(French)
| 4 +2 | Select Early vs Select Compare |
Bertrand Leduc
|
Change log
Nov 12, 2018 14:51: Bertrand Leduc Created KOG entry
Proposed translations
+2
14 mins
Bertrand Leduc
United Kingdom
United Kingdom
Native in French
Specializes in field
United Kingdom
Medical translator and proofreader
Native in: French (Variant: Standard-France)
Works in: English to French
Related KudoZ points
:
389
Selected
Select Early vs Select Compare
Ne pas traduire
--------------------------------------------------
Note added at 15 minutes (2018-11-07 16:31:28 GMT)
--------------------------------------------------
Il s'agit de noms d'études cliniques.
"SELECT-EARLY is the fifth pivotal trial that will support regulatory submissions for upadacitinib in rheumatoid arthritis later this year," said Michael Severino, M.D., executive vice president, research and development and chief scientific officer, AbbVie. "Results from SELECT-EARLY further support our belief that upadacitinib has the potential to be an important new treatment option for patients with rheumatoid arthritis."
https://news.abbvie.com/news/upadacitinib-monotherapy-meets-...
--------------------------------------------------
Note added at 15 minutes (2018-11-07 16:31:28 GMT)
--------------------------------------------------
Il s'agit de noms d'études cliniques.
"SELECT-EARLY is the fifth pivotal trial that will support regulatory submissions for upadacitinib in rheumatoid arthritis later this year," said Michael Severino, M.D., executive vice president, research and development and chief scientific officer, AbbVie. "Results from SELECT-EARLY further support our belief that upadacitinib has the potential to be an important new treatment option for patients with rheumatoid arthritis."
https://news.abbvie.com/news/upadacitinib-monotherapy-meets-...
4 KudoZ points awarded for this answer.
Something went wrong...